Thymosin Alpha 1

Thymosin Alpha-1 is a synthetic peptide made from 28 amino acids. It was first isolated from thymosin fraction 5, a substance derived from the thymus gland, and is classified within the thymic peptide family as an immune-related research compound.

Thymosin Alpha-1 (Tα1) is a short peptide — a chain of amino acids — first identified within thymosin fraction 5, a substance derived from the thymus gland, and now reproduced synthetically for laboratory reference. Key points drawn from published literature:

• Structure: 28 amino acids; first identified within thymosin fraction 5, a thymus-derived extract.
• Category: Grouped with the thymic peptide family, associated in research literature with immune-system study.
• Regulatory status: Approved as a pharmaceutical drug under other names in select countries outside the U.S.; not FDA-approved in the United States.
• Common reference name: Often abbreviated Tα1 or TA1 in scientific literature and supplier catalogs.

This overview reflects published research literature only; it does not evaluate safety for any use. It describes the compound as a subject of laboratory study, not as a product for administration, and Preppin Peppers does not sell it for consumption. The sections below outline packaging and cartridge-handling considerations relevant to laboratory work, not directions for use in a person or animal in any context.

What it is

Thymosin Alpha-1 is a synthetic (man-made) peptide — a short chain of amino acids, the building blocks used to construct proteins. It consists of 28 amino acids linked in a single sequence.

• Origin: first identified as a fragment of thymosin fraction 5, a substance derived from the thymus gland.
• Thymus gland: a small organ in the chest involved in the training of immune cells.
• Naming: "thymosin" reflects its thymus-derived origin, and "alpha-1" identifies its specific fraction within that source material.
• Classification: grouped within the thymic peptide family, a set of naturally occurring signaling molecules tied to the thymus and to immune cell development.
• Supply form: provided here strictly for laboratory and research use, not for human or animal administration.

Research context and categorization

Thymosin Alpha-1 is categorized as an immune peptide, grouped alongside related thymic peptides such as thymalin and thymulin. Published research discusses it in the context of immune modulation — a general term for how immune system activity is adjusted or kept in balance. This categorization framework helps position it relative to other thymic peptides studied for similar research applications.

A recurring research focus is its studied role in T-cell maturation: precursor T-cells are immature immune cells, while mature T-cells are fully developed and functional. Research literature sometimes frames this as recruits completing training before becoming active immune cells.

Beyond that core focus, published research references this peptide across several additional categories:

• Viral conditions, including hepatitis B and hepatitis C
• Immune-function research adjacent to oncology (cancer research)
• Sepsis (a serious, body-wide response to infection) and immune response to infectious disease
• General immune-resilience and aging-related research

Regulatory status varies by country. Under the brand name Zadaxin, this peptide holds pharmaceutical approval in roughly three dozen countries. It does not hold that status in the United States and is not FDA-approved here. Everything referenced in this section reflects categorization and framing found in published research literature, not confirmed or approved outcomes.

Status

Regulatory Status

In the United States, Thymosin Alpha-1 is a research-only compound and is not FDA-approved; PreppinPeppers does not sell it. Regulatory treatment of this peptide varies by country and can involve different classifications and restrictions depending on jurisdiction. In the U.S., its status under compounding pharmacy regulations has shifted over time as rules have been revised, so licensed-pharmacy availability can vary by jurisdiction and date.

Sport Status

Thymosin Alpha-1 is not specifically named on the current WADA Prohibited List, the global roster of substances banned in competitive sport. This differs from the related peptide Thymosin Beta-4 (including products like TB-500), which is banned under the growth factors and growth factor modulators category. The Prohibited List is updated annually, and some compounds can fall under its non-approved-substances catch-all (S0). Athletes should confirm current status directly with their sport's governing body before making any decisions.

Reconstitution notes (general)

Thymosin Alpha-1 typically comes as a lyophilized (freeze-dried) powder. Before lab use, it is reconstituted, meaning the powder is mixed with a diluent - commonly bacteriostatic water, which is sterile water with a small amount of benzyl alcohol added as a preservative - to return it to liquid form. Reconstitution kits are available separately for labs setting up this workflow.

The concentration of the resulting solution is simple to calculate: divide the milligrams in the vial by the milliliters of diluent added. For example, a 5 mg vial mixed with 2.5 mL gives 2 mg/mL. Use the peptide calculator to skip the math.

The benzyl alcohol preservative is what distinguishes bacteriostatic water from plain sterile water, and it is why a reconstituted vial can support multiple withdrawals instead of just one. Once mixed, solutions are typically kept refrigerated, with handling and storage details specific to the product's own labeling.

Dilution and handling notes (compound-specific)

Common vial sizes are 5 mg and 10 mg. Most lab preparations use roughly 1 mL to 3 mL of water per vial, chosen mainly for ease of measurement rather than any chemical requirement.

Typical preparation examples include:

• A 5 mg vial mixed with about 2.5 mL to 3 mL of water, giving roughly 1.67 mg/mL to 2 mg/mL.
• A 10 mg vial mixed with about 2 mL to 3 mL, giving roughly 3.3 mg/mL to 5 mg/mL.

Handling Best Practices

Thymosin Alpha-1 dissolves easily in water. At the concentrations above, it typically does not cloud, gel, or clump, making it one of the more cooperative peptides to work with at the bench.

Because it is a somewhat delicate peptide, the main handling tip is how you add the water. Do not aim the stream directly at the powder pellet. Instead, angle it down the inner glass wall and let it run slowly over the powder, then let the vial sit and swirl gently rather than shaking it.

Shaking forces air into the solution, creates foam, and can cause the peptide to clump (aggregation). If material remains undissolved, gentle swirling and a short rest will usually finish the job without added heat.

Diluent choice and stability

A frequent bench question is whether benzyl alcohol - the preservative in bacteriostatic water - affects peptide stability. Reference literature generally reports benzyl alcohol as compatible with most reconstituted peptides at typical low concentrations, though sensitivity varies by peptide. Consult compound-specific reference data rather than assuming uniform behavior across peptides.

The reconstituted solution is also sensitive to light, so keep it away from direct light during storage.

Key point: Avoid shaking the vial during reconstitution. Run water gently down the inner glass wall and swirl slowly to prevent foaming and peptide aggregation (clumping).

Handling and storage

Reconstituted peptide is a fragile solution — how you store and handle it directly affects how long it stays stable in the vial.

• Temperature: Refrigerate at 2–8°C, away from direct light, immediately after mixing.
• Vial access: Wipe the rubber stopper with an alcohol swab before each draw, and label the vial with the reconstitution date so age is always known at a glance.
• Usable window: Reconstituted solution is generally treated as usable for about four weeks under refrigeration; when references disagree, default to the shorter estimate.
• Freeze-thaw: Never freeze a reconstituted vial and thaw it repeatedly — each cycle degrades stability further.
• Discard triggers: Any cloudiness, discoloration, or visible particulate means the vial should be discarded rather than used.

Frequently asked questions